11 – 20 of 100
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Protocol for the T-REX-trial : Tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases - An open, multicentre, randomised non-inferiority phase 3 trial
(
- Contribution to journal › Article
-
Mark
A prospective cohort study identifying radiologic and tumor related factors of importance for breast conserving surgery after neoadjuvant chemotherapy
(
- Contribution to journal › Article
-
Mark
Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study
(
- Contribution to journal › Article
-
Mark
The implementation of NILS : A web-based artificial neural network decision support tool for noninvasive lymph node staging in breast cancer
(
- Contribution to journal › Article
-
Mark
Gene expression in metastatic breast cancer—patterns in primary tumors and metastatic tissue with prognostic potential
(
- Contribution to journal › Article
- 2022
-
Mark
One-year recovery from breast cancer : Importance of tumor and treatment-related factors, resilience, and sociodemographic factors for health-related quality of life
(
- Contribution to journal › Article
-
Mark
Choice of High-Throughput Proteomics Method Affects Data Integration with Transcriptomics and the Potential Use in Biomarker Discovery
(
- Contribution to journal › Article
-
Mark
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer
(
- Contribution to journal › Article
-
Mark
Prediction of node negative breast cancer and high disease burden through image analysis software on mammographic images and clinicopathological data
2022)(
- Contribution to conference › Abstract